Welcome to LookChem.com Sign In|Join Free
  • or
Chlorpromazine is a phenothiazine derivative with sedative properties, commonly used in human and veterinary medicine. It is known for its unique sedative effect and has a wide range of applications in treating various conditions.

50-53-3

Post Buying Request

50-53-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50-53-3 Usage

Uses

Used in Psychiatric Practice:
Chlorpromazine is used as an antipsychotic and antiemetic agent for managing psychomotor excitement in patients with schizophrenia, chronic paranoid, manic-depressive conditions, neurosis, alcohol psychosis, and neurosis accompanied by excitement, fear, stress, and insomnia.
Used in Anesthesiological Practice:
Chlorpromazine is used as a potentiator for narcosis due to its sedative effect and moderate anticonvulsant action.
Used in FDA-approved Human Treatments:
Chlorpromazine is approved by the FDA for the management of psychotic disorders, control of nausea and vomiting, relief of apprehension before surgery, acute intermittent porphyria, adjunctive treatment of tetanus, intractable hiccups, combativeness or explosive hyperexcitable behavior in children aged 1-12 years, and short-term treatment of hyperactivity in children with symptoms of impulsivity, difficulty sustaining attention, aggressiveness, mood lability, and poor frustration tolerance.
Used in Off-label Treatments:
Chlorpromazine is used off-label for the treatment of behavioral symptoms associated with dementia in the elderly and psychosis and agitation related to Alzheimer's dementia, managing agitation in terminal cancer patients, autonomic dysreflexia, cancer pain, adjunctive treatment of cholera, migraine headaches, opioid withdrawal, ocular pain, paralytic ileus, and phantom limb syndrome.
Used in Veterinary Medicine:
In veterinary medicine, chlorpromazine has been largely replaced by acepromazine due to its more favorable pharmacokinetic profile. However, it may still be used as an antiemetic for small animals or for preoperative sedation, and for the management of hypertension in dogs and cats. It is also used to avoid mortality of pigs during transportation.

Hazard

Toxic by ingestion.

Contact allergens

This phenothiazine with sedative properties is used in human medicine and induced contact dermatitis in nurses or those working in the pharmaceutical industry. It is also used in veterinary medicine to avoid mortality of pigs during transportation. It is a sensitizer and a photosensitizer.

Synthesis

Chlorpromazine, 2-chloro-10-(3-dimethylaminopropyl)phenothiazine, is synthesized in an analogous manner, except by alkylation of 2-chlorophenothiazine with 3-dimethylaminopropylchloride.

Environmental Fate

Acute and chronic toxicity due to chlorpromazine generally manifests as an extension of normal pharmacological activity. The precise mechanism of action of chlorpromazine, and other phenothiazines, is unknown; however, it is thought to primarily involve antagonism of dopaminergic (D2) neurotransmission at synaptic sites and blockade of postsynaptic dopamine receptor sites at the subcortical levels of the reticular formation, limbic system, and hypothalamus. This activity contributes to chlorpromazine’s extrapyramidal reactions. Chlorpromazine also has strong central and peripheral activity directed against adrenergic receptors and weak activity against serotonergic, histaminic (H1), and muscarinic receptors. Chlorpromazine has slight ganglionic blocking action. Chlorpromazine is known to depress vasomotor reflexes medicated by the hypothalamus and/or brain stem; inhibit release of growth hormone; antagonize secretion of prolactin release-inhibiting hormone; and reduce secretion of corticotropin-regulatory hormone. Chlorpromazine also has direct effects on cardiac myocytes; it can induce early after-depolarizations, block depolarizing sodium channels, and cause significant prolongation of the QTc interval. Chlorpromazine may be irritating to eyes, mucous membranes, and skin. Contact and inhalation should be avoided.

Metabolic pathway

The in vivo photodegradation of chlorpromazine in rat skin exposed to UV-A results in the formation of promazine and 2-hydroxypromazine in irradiated rats, but not in the skin of rats kept in the dark. Chlorpromazine sulfoxide is a major metabolite of chlorpromazine, found in smaller quantity in the skin of irradiated rats compared with those kept in the dark. Chlorpromazine sulfoxide is not a photoproduct of chlorpromazine under the experimental conditions.

Toxicity evaluation

Chlorpromazine exists as both a vapor and particulate at ambient atmospheric conditions. Chlorpromazine vapor is degraded by photochemically produced hydroxyl radicals with an estimated half-life of 1.6 h. Chlorpromazine particulate is removed by wet or dry deposition. Chlorpromazine is likely to be immobile in soil (Koc 9900, pKa 9.3) and to adsorb to sediment if released into water. It is not expected to volatilize from soil or water. There is high potential for bioconcentration.

Check Digit Verification of cas no

The CAS Registry Mumber 50-53-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 50-53:
(4*5)+(3*0)+(2*5)+(1*3)=33
33 % 10 = 3
So 50-53-3 is a valid CAS Registry Number.
InChI:InChI=1/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H

50-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name chlorpromazine

1.2 Other means of identification

Product number -
Other names Esmind

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Veterinary Drug: TRANQUILLIZING_AGENT
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50-53-3 SDS

50-53-3Synthetic route

C11H16ClIN2
1219602-20-6

C11H16ClIN2

2-bromothiophenol
6320-02-1

2-bromothiophenol

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With copper(l) iodide; potassium carbonate; L-proline In ethyl methyl ether at 90 - 110℃; Inert atmosphere;78%
formaldehyd
50-00-0

formaldehyd

2-chloro-10-(3-aminopropyl)phenothiazine
2095-17-2

2-chloro-10-(3-aminopropyl)phenothiazine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With formic acid In water at 80℃; for 8h; Eschweiler-Clark Amine Methylation; Microwave irradiation;66%
2-bromo-4-chloroiodobenzene
31928-44-6

2-bromo-4-chloroiodobenzene

2-bromothiophenol
6320-02-1

2-bromothiophenol

1-amino-3-(dimethylamino)propane
109-55-7

1-amino-3-(dimethylamino)propane

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With 1,1'-bis-(diphenylphosphino)ferrocene; tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate In toluene at 60 - 160℃; for 2.33333h; Microwave irradiation;50%
2-chlorophenothiazine
92-39-7

2-chlorophenothiazine

3-(Dimethylamino)propyl chloride
109-54-6

3-(Dimethylamino)propyl chloride

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With sodium amide
(i) NaNH2, toluene, (ii) /BRN= 605294/; Multistep reaction;
With potassium hydroxide; potassium carbonate; tetra(n-butyl)ammonium hydrogensulfate toluene 1.) room temp., 2 h, 2.) reflux, 18 h; Yield given. Multistep reaction;
3-Dimethylamino-1-propanol
3179-63-3

3-Dimethylamino-1-propanol

2-chloro-phenothiazine-10-carbonyl chloride
36798-98-8

2-chloro-phenothiazine-10-carbonyl chloride

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With toluene Erhitzen des Reaktionsprodukts unter vermindertem Druck auf 210-220grad;
3-(2-chloro-10H-phenothiazin-10-yl)propanonitrile
4414-83-9

3-(2-chloro-10H-phenothiazin-10-yl)propanonitrile

A

2-chloro-10-(3-aminopropyl)phenothiazine
2095-17-2

2-chloro-10-(3-aminopropyl)phenothiazine

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With nickel; dimethyl amine; benzene at 110 - 116℃; under 58840.6 Torr; Hydrogenation;
N'-[2-(2-bromo-phenylsulfanyl)-5-chloro-phenyl]-N,N-dimethyl-propanediyldiamine
109454-48-0

N'-[2-(2-bromo-phenylsulfanyl)-5-chloro-phenyl]-N,N-dimethyl-propanediyldiamine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With copper; potassium carbonate; N,N-dimethyl-formamide
chlorpromazine sulfoxide
969-99-3

chlorpromazine sulfoxide

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With iron; acetic acid; xylene
1-(2-chloro-phenothiazin-10-yl)-3-methanesulfonyloxy-propane
41951-57-9

1-(2-chloro-phenothiazin-10-yl)-3-methanesulfonyloxy-propane

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With dimethyl amine
bis-[3-(2-chloro-phenothiazin-10-yl)-propyl]-methyl-amine
103278-35-9

bis-[3-(2-chloro-phenothiazin-10-yl)-propyl]-methyl-amine

A

10-Allyl-2-chlorophenothiazine
63615-79-2

10-Allyl-2-chlorophenothiazine

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With sodium hydroxide; methyl iodide
2-chloro-10-(3-chloropropyl)-10H-phenothiazine
2765-59-5

2-chloro-10-(3-chloropropyl)-10H-phenothiazine

dimethyl amine
124-40-3

dimethyl amine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In ethanol
dopamine
51-61-6

dopamine

chloropromazine cation radical
50-53-3

chloropromazine cation radical

A

dopaminoquinone
50673-96-6

dopaminoquinone

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In hydrogenchloride Rate constant; pH=1.5;
2-chlorophenothiazine
92-39-7

2-chlorophenothiazine

3-(Dimethylamino)propyl chloride
109-54-6

3-(Dimethylamino)propyl chloride

A

2-chloro-10-methyl-10H-phenothiazine
19607-03-5

2-chloro-10-methyl-10H-phenothiazine

B

10-Allyl-2-chlorophenothiazine
63615-79-2

10-Allyl-2-chlorophenothiazine

C

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With sodium hydroxide In chlorobenzene; toluene for 4.5h; Heating; Yield given. Yields of byproduct given;
carbon dioxide
124-38-9

carbon dioxide

2-chloro-10-<3-N-trimethylsilyl, 3-N-methylaminopropyl> phenothiazine

2-chloro-10-<3-N-trimethylsilyl, 3-N-methylaminopropyl> phenothiazine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride 1.) THF, -45 deg C - 60 deg C, 2.) 60 deg C, 10 min; Yield given. Multistep reaction;
Norepinephrine
138-65-8

Norepinephrine

chloropromazine cation radical
50-53-3

chloropromazine cation radical

A

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

B

4-(2-Amino-1-hydroxy-ethyl)-[1,2]benzoquinone
14309-96-7

4-(2-Amino-1-hydroxy-ethyl)-[1,2]benzoquinone

Conditions
ConditionsYield
In hydrogenchloride Rate constant; pH=7;
Epinephrine
329-65-7

Epinephrine

chloropromazine cation radical
50-53-3

chloropromazine cation radical

A

adrenaline o-quinone
672-73-1, 162706-73-2

adrenaline o-quinone

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In hydrogenchloride Rate constant; pH=7;
aminopyrine
58-15-1

aminopyrine

chlorpromazine semiquinone cation radical

chlorpromazine semiquinone cation radical

A

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

B

aminopyrine radical cation
58-15-1

aminopyrine radical cation

Conditions
ConditionsYield
Rate constant; pH 6;
[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-(2-methyl-acryloyloxymethyl)-ammonium; chloride
76637-15-5

[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-(2-methyl-acryloyloxymethyl)-ammonium; chloride

A

formaldehyd
50-00-0

formaldehyd

B

poly(methacrylic acid)
79-41-4

poly(methacrylic acid)

C

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In water at 21℃; pH=8.8, ionic strength 0.1 M KCl; other pH, other temp.; hydrolysis rate;
Benzoyloxymethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; chloride
76637-14-4

Benzoyloxymethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; chloride

A

formaldehyd
50-00-0

formaldehyd

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

C

benzoic acid
65-85-0

benzoic acid

Conditions
ConditionsYield
In water at 21℃; pH=8.2, ionic strength 0.1 M KCl; other pH; hydrolysis rate;
dopamine
51-61-6

dopamine

chlorpromazine semiquinone cation radical

chlorpromazine semiquinone cation radical

A

dopaminoquinone
50673-96-6

dopaminoquinone

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
Kinetics; Rate constant; in constant ionic strength (0.8 M) mixtures of HClO4 and NaClO4 in 40percent MeO/H2O (w/w) with a pH between 0.1 and 1.5;
chloropromazine cation radical
50-53-3

chloropromazine cation radical

4-methyl-1,2-dihydroxybenzene
452-86-8

4-methyl-1,2-dihydroxybenzene

A

4-methylbenzo-1,2-quinone
3131-54-2

4-methylbenzo-1,2-quinone

B

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In hydrogenchloride Rate constant; pH=7;
benzyl-<3-(2-chloro-phenothiazin-10-yl)-propyl>-dimethyl-ammonium-methanesulfonate

benzyl-<3-(2-chloro-phenothiazin-10-yl)-propyl>-dimethyl-ammonium-methanesulfonate

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With palladium on activated charcoal; acetic acid Hydrogenation;
2-chlorophenothiazine
92-39-7

2-chlorophenothiazine

methanesulfonic acid-<3-dimethylamino-propyl ester

methanesulfonic acid-<3-dimethylamino-propyl ester

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With n-butyllithium; diethyl ether
2-chlorophenothiazine
92-39-7

2-chlorophenothiazine

toluene-4-sulfonic acid-<3-dimethylamino-propyl ester>-hydrochloride

toluene-4-sulfonic acid-<3-dimethylamino-propyl ester>-hydrochloride

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
With xylene
2-chloro-N-methyl-10H-phenothiazine-10-propanamine hydrochloride
3953-65-9

2-chloro-N-methyl-10H-phenothiazine-10-propanamine hydrochloride

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (NH4)2SO4 / 110 °C
2: 2.) LiAlH4 / 1.) THF, -45 deg C - 60 deg C, 2.) 60 deg C, 10 min
View Scheme
chlorpromazine hydrochloride
69-09-0

chlorpromazine hydrochloride

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous H2O2; ethanol
2: iron-powder; acetic acid; xylene
View Scheme
With potassium carbonate In water pH=10; Inert atmosphere;
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

tert-butyl (2-(2-((4-(chloromethyl)benzyl)oxy)ethoxy)ethyl)carbamate

tert-butyl (2-(2-((4-(chloromethyl)benzyl)oxy)ethoxy)ethyl)carbamate

3-(2-chloro-10H-phenothiazin-10-yl)-N-(4-(11,11-dimethyl-9-oxo-2,5,10-trioxa-8-azadodecyl)benzyl)-N,N-dimethylpropan-1-aminium chloride

3-(2-chloro-10H-phenothiazin-10-yl)-N-(4-(11,11-dimethyl-9-oxo-2,5,10-trioxa-8-azadodecyl)benzyl)-N,N-dimethylpropan-1-aminium chloride

Conditions
ConditionsYield
In acetone at 40℃; for 48h; Inert atmosphere; Reflux;97%
2-aminopyridine
504-29-0

2-aminopyridine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

10-(3-(dimethylamino)propyl)-N-(pyridin-2-yl)-10H-phenothiazin-2-amine

10-(3-(dimethylamino)propyl)-N-(pyridin-2-yl)-10H-phenothiazin-2-amine

Conditions
ConditionsYield
With methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II); potassium hydroxide In water; toluene at 110℃; Flow reactor;95%
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

chlorpromazine semiquinone cation radical

chlorpromazine semiquinone cation radical

Conditions
ConditionsYield
With GLUTATHIONE; isopropyl alcohol; acetone In water Rate constant; Product distribution; Irradiation; pH=3; pulse radiolysis; other thiol reagents and CPZ concentrations;91%
With halothane peroxyl radical In various solvent(s) Rate constant; Ambient temperature; Irradiation; pH=7; pulse radiolysis; different CZ concentrations;54 % Spectr.
With dihydrogen peroxide; horseradish peroxidase In acetate buffer pH=4.5; Kinetics; Further Variations:; Reagents; Oxidation;
With hydroxyl pH=7; Kinetics; aq. phosphate buffer;
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-ol
3926-64-5

10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-ol

Conditions
ConditionsYield
With dicyclohexyl-(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine; boric acid; palladium diacetate; caesium carbonate In 1-methyl-pyrrolidin-2-one at 100℃; for 14h; Schlenk technique; Inert atmosphere;87%
With water for 120h; Irradiation;
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

chlorpromazine sulfoxide
969-99-3

chlorpromazine sulfoxide

Conditions
ConditionsYield
In acetonitrile Electrolysis;83%
With hydrogenchloride; sodium nitrite In water for 2h; Product distribution; oxidation of phenothiazine salts to their sulfoxides with aqueous nitrous acid; hydrogen peroxide oxidation;74%
With hydrogenchloride; sodium nitrite In water for 2h;74%
chloromethyl benzoate
5335-05-7

chloromethyl benzoate

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

Benzoyloxymethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; chloride
76637-14-4

Benzoyloxymethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; chloride

Conditions
ConditionsYield
In acetone81.5%
carbonochloridic acid 1-chloro-ethyl ester
50893-53-3

carbonochloridic acid 1-chloro-ethyl ester

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

2-chloro-N-(1-chloroethoxycarbonyl)-N-methyl-10H-phenothiazine-10-propanamine

2-chloro-N-(1-chloroethoxycarbonyl)-N-methyl-10H-phenothiazine-10-propanamine

Conditions
ConditionsYield
In 1,2-dichloro-ethane for 1h; Substitution; Heating;81%
Chloromethyl methacrylate
27550-73-8

Chloromethyl methacrylate

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-(2-methyl-acryloyloxymethyl)-ammonium; chloride
76637-15-5

[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-(2-methyl-acryloyloxymethyl)-ammonium; chloride

Conditions
ConditionsYield
In acetone79%
indole
120-72-9

indole

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

3-(2-(1H-indol-3-yl)-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine

3-(2-(1H-indol-3-yl)-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine

Conditions
ConditionsYield
With Cy-DHTP*HBF4; palladium diacetate; lithium tert-butoxide In toluene at 20 - 110℃; for 21h; Inert atmosphere; Sealed tube;65%
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester
21085-72-3

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester

chlorpromazine N+-glucuronide chloride
86492-49-1

chlorpromazine N+-glucuronide chloride

Conditions
ConditionsYield
With XAD-2 ion-exchange resin; sodium hydrogencarbonate In water; benzene for 72h; Ambient temperature;46%
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester
21085-72-3

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester

A

chlorpromazine N+-glucuronide chloride
86492-49-1

chlorpromazine N+-glucuronide chloride

B

[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-((2R,3R,4S,5S,6S)-3,4,5-triacetoxy-6-methoxycarbonyl-tetrahydro-pyran-2-yl)-ammonium; bromide
145823-11-6

[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-((2R,3R,4S,5S,6S)-3,4,5-triacetoxy-6-methoxycarbonyl-tetrahydro-pyran-2-yl)-ammonium; bromide

C

Hydrogen carbonate[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-((2R,3R,4S,5S,6S)-3,4,5-triacetoxy-6-carboxy-tetrahydro-pyran-2-yl)-ammonium;
145823-13-8

Hydrogen carbonate[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-((2R,3R,4S,5S,6S)-3,4,5-triacetoxy-6-carboxy-tetrahydro-pyran-2-yl)-ammonium;

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; benzene for 72h; Ambient temperature;A 46%
B n/a
C n/a
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

A

Chlorpromazine oxide
1672-76-0

Chlorpromazine oxide

B

chlorpromazine sulfoxide
969-99-3

chlorpromazine sulfoxide

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid; sodium hydroxide In dichloromethane at 0℃; for 4h;A 40%
B 10%
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

A

7-hydroxychlorpromazine
2095-62-7

7-hydroxychlorpromazine

B

2-chloro-10-(3-dimethylamino-propyl)-10H-phenothiazin-1-ol
3926-66-7

2-chloro-10-(3-dimethylamino-propyl)-10H-phenothiazin-1-ol

C

3-hydroxyl CPZ
3930-47-0

3-hydroxyl CPZ

D

chlorpromazine sulfoxide
969-99-3

chlorpromazine sulfoxide

Conditions
ConditionsYield
Stage #1: 2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine With ethylenediaminetetraacetic acid trisodium salt; oxygen; manganese (II) acetate tetrahydrate; ascorbic acid In water pH=4; Udenfriend reaction;
Stage #2: With ferrous(II) sulfate heptahydrate; ethylenediaminetetraacetic acid trisodium salt; oxygen In water at 45℃; for 2h; Udenfriend reaction;
A n/a
B 0.4%
C 0.84%
D 0.58%
2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

chlorpromazine N',S-dioxide
10404-90-7

chlorpromazine N',S-dioxide

Conditions
ConditionsYield
With ethanol; dihydrogen peroxide
With dihydrogen peroxide In ethanol
With dihydrogen peroxide In ethanol for 24h; Ambient temperature;
Multi-step reaction with 2 steps
1: aq. H2O2, NH3 / ethanol / 60 h
2: aq. H2O2 / ethanol / 84 h
View Scheme
Multi-step reaction with 2 steps
1: 3-chloro-benzenecarboperoxoic acid; sodium hydroxide / dichloromethane / 4 h / 0 °C
2: 3-chloro-benzenecarboperoxoic acid; sodium hydroxide / dichloromethane / 4 h / 0 °C
View Scheme
9-(bromomethyl)acridine
1556-34-9

9-(bromomethyl)acridine

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

acridin-9-ylmethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; bromide
56265-45-3

acridin-9-ylmethyl-[3-(2-chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium; bromide

Conditions
ConditionsYield
In acetonitrile Ambient temperature;
2-bromo-1-phenyl-ethanone oxime
14181-72-7, 17082-13-2, 17082-14-3

2-bromo-1-phenyl-ethanone oxime

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine
50-53-3

2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine

[3-(2-chloro-phenothiazin-10-yl)-propyl]-(2-hydroxyimino-2-phenyl-ethyl)-dimethyl-ammonium; bromide
19337-44-1

[3-(2-chloro-phenothiazin-10-yl)-propyl]-(2-hydroxyimino-2-phenyl-ethyl)-dimethyl-ammonium; bromide

Conditions
ConditionsYield
In diethyl ether

50-53-3Relevant academic research and scientific papers

Spatially Resolved Spectroelectrochemical Examination of the Oxidation of Dopamine by Chlorpromazine Cation Radical

Deputy, Andrew,Wu, Huan-Ping,McCreery, Richard L.

, p. 3620 - 3624 (1990)

Spatially resolved absorption measurements of electrogenerated chlorpromazine cation radical (CPZ.+) were used to monitor the kinetics of the homogeneous oxidation of dopamine (DA) in the solution near planar and cylindrical electrodes.Complete concentration vs distance profiles for CPZ.+ were obtained for both planar and convergent diffusion and were used to determine the reaction mechanism and rate constants.The oxidation of DA by CPZ.+ to dopamine orthoquinone involves successive one-electron transfers, and the results are inconsistent with disproportionation of the DA semiquinone.The observed kinetics and rate-limiting step were dependent on the position within the diffusion layer.Near the electrode surface the rate law is first order in CPZ.* and DA, and a second-order rate constant of 2.1 x 105 M-1s-1 was obtained.Further away from the electrode the reaction is second order in CPZ.+ due to the involvement of the second step, and several kinetic parameters for the second electron transfer were obtained.A change in diffusion geometry which occurs at a microwire electrode further perturbs local concentration distributions, and the reaction reaches equilibrium under certain conditions.In all cases, the observed rate laws were consistent with a general expression for the stepwise electron transfer.This report represents the first application of spatially resolved spectroelectrochemistry to a kinetic system and provides unprecedented detail about the CPZ.+/DA reaction.

Halogenated Alkylperoxyl Radicals as Oxidants: Effects of Solvents and of Substituents on Rates of Electron Transfer

Alfassi, Zeev B.,Mosseri, S.,Neta, P.

, p. 3383 - 3385 (1987)

The peroxyl radicals CCl3O2., CHCl2O2., CH2ClO2., CCl3CCl2O2., CFCl2O2., CH3CCl2O2., CF3CHClO2., and CBr3O2. were produced by pulse radiolysis of aerated solutions of the appropriate halogen compound in 2-propanol or 2-propanol-water solutions.Rate constants for one-electron oxidation of chloropromazine by these radicals were determined by kinetic spectrophotometry in various solvent mixtures.The second-order rate constants were found to vary from 1 * 105 to 1 * 109 M-1 s-1.They depend very strongly on the solvent polarity and a reasonable correlation is obtained between log k for a certain peroxyl radical and the dielectric constant of the solvent mixture.The rate constants in the same solvent are strongly dependent of the substituents on the methylperoxyl radical and give a good correlation with the polar substituent constants ?*.

One-Pot Tandem Access to Phenothiazine Derivatives from Acetanilide and 2-Bromothiophenol via Rhodium-Catalyzed C-H Thiolation and Copper-Catalyzed C-N Amination

Rui, Xiyan,Wang, Chao,Si, Dongjuan,Hui, Xuechao,Li, Keting,Wen, Hongmei,Li, Wei,Liu, Jian

, p. 6622 - 6632 (2021/05/29)

A one-pot and step economic reaction involving Rh(III)-catalyzed C-H thiolation and relay Cu(II)-catalyzed C-N amination of acetanilide and 2-bromothiophenol is reported here, with several valuable phenothiazine products obtained. This synthesis protocol proceeds from easily starting materials, demonstrating high atom economy, broad substrate scope, and good yield. Furthermore, the directing group can be easily eliminated, and chlorpromazine is provided in a large scale; thus this synthesis protocol could be utilized to construct phenothiazine scaffolds.

A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential

Uliassi, Elisa,Pena-Altamira, Luis Emiliano,Morales, Aixa V.,Massenzio, Francesca,Petralla, Sabrina,Rossi, Michele,Roberti, Marinella,Martinez Gonzalez, Loreto,Martinez, Ana,Monti, Barbara,Bolognesi, Maria Laura

, p. 279 - 294 (2018/10/20)

Overcoming the lack of effective treatments and the continuous clinical trial failures in neurodegenerative drug discovery might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting simultaneously neuroprotection and neuroregeneration. In the studies reported herein, we sought to identify small molecules that might exert neuroprotective and neuroregenerative potential as tools against neurodegenerative diseases. In doing so, we started from the reported neuroprotective/neuroregenerative mechanisms of psychotropic drugs featuring a tricyclic alkylamine scaffold. Thus, we designed a focused-chemical library of 36 entries aimed at exploring the structural requirements for efficient neuroprotective/neuroregenerative cellular activity, without the manifestation of toxicity. To this aim, we developed a synthetic protocol, which overcame the limited applicability of previously reported procedures. Next, we evaluated the synthesized compounds through a phenotypic screening pipeline, based on primary neuronal systems. Phenothiazine 2Bc showed improved neuroregenerative and neuroprotective properties with respect to reference drug desipramine (2Aa). Importantly, we have also shown that 2Bc outperformed currently available drugs in cell models of Alzheimer's and Parkinson's diseases and attenuates microglial activation by reducing iNOS expression.

The design and synthesis of an antibacterial phenothiazine-siderophore conjugate

Tarapdar, Abed,Norris, James K.S.,Sampson, Oliver,Mukamolova, Galina,Hodgkinson, James T.

supporting information, p. 2646 - 2650 (2018/11/03)

Siderophore-antibiotic conjugates consist of an antibiotic covalently linked by a tether to a siderophore. Such conjugates can demonstrate enhanced uptake and internalisation to the bacterial cell resulting in significantly reduced MIC values and extended spectrum of activity. Phenothiazines are a class of small molecules that have been identified as a potential treatment for multidrug resistant tuberculosis and latent TB. Herein we report the design and synthesis of the first phenothiazine-siderophore conjugate. A convergent synthetic route was developed whereby the functionalised phenothiazine component was prepared in four steps and the siderophore component also prepared in four steps. In M. smegmatis the functionalised phenothiazine demonstrated an equipotent MIC value in direct comparison to the parent phenothiazine from which it was derived. The final conjugate was synthesised by amide bond formation between the two components and global deprotection of the PMB protecting groups to unmask the catechol iron chelating groups of the siderophore. The synthesis is readily amenable to the preparation of analogues whereby the siderophore component of the conjugate can be modified. The route will be used to prepare a library of siderophore-phenothiazine conjugates for full biological evaluation of much needed new antibacterial agents.

A mechanistic study on the disproportionation and oxidative degradation of phenothiazine derivatives by manganese(III) complexes in phosphate acidic media

Wisniewska, Joanna,Rzesnicki, Pawel,Topolski, Adrian

scheme or table, p. 767 - 774 (2012/07/01)

The oxidative degradation of phenothiazine derivatives (PTZ) by manganese(III) was studied in the presence of a large excess of manganese(III)-pyrophosphate (P2O7 2-), phosphate (PO4 3-), and H+ ions using UV-vis. spectroscopy. The first irreversible step is a fast reaction between phenothiazine and manganese pyrophosphate leading to the complete conversion to a stable phenothiazine radical. In the second step, the cation radical is oxidized by manganese to a dication, which subsequently hydrolyzes to phenothiazine 5-oxide. The reaction rate is controlled by the coordination and stability of manganese(III) ion influenced by the reduction potential of these ions and their strong ability to oxidize many reducing agents. The cation radical might also be transformed to the final product in another competing reaction. The final product, phenothiazine 5-oxide, is also formed via a disproportionation reaction. The kinetics of the second step of the oxidative degradation could be studied in acidic phosphate media due to the large difference in the rates of the first and further processes. Linear dependences of the pseudo-first-order rate constants (k obs) on [Mn III] with a significant non-zero intercept were established for the degradation of phenothiazine radicals. The rate is dependent on [H+] and independent of [PTZ] within the excess concentration range of the manganese(III) complexes used in the isolation method. The kinetics of the disproportionation of the phenothiazine radical have been studied independently from the further oxidative degradation process in acidic sulphate media. The rate is inversely dependent on [PTZ+.], dependent on [H+], and increases slightly with decreasing H+ concentration. Mechanistic consequences of all these results are discussed.

Assembly of substituted phenothiazines by a sequentially controlled CuI/L-proline-catalyzed cascade C-S and C-N bond formation

Dawei, Ma.,Geng, Qian,Zhang, Hui,Jiang, Yongwen

supporting information; experimental part, p. 1291 - 1294 (2010/05/17)

(Chemical equation presented) In the pro-line of fire: A general and efficient cascade reaction approach to substituted phenothiazines, which relies on controlled sequential Cul/L-prolinecatalyzed C-S and C-N bond formations, is described. DMSO = dimethylsulfoxide.

Palladium-catalyzed three-component approach to promazine with formation of one carbon-sulfur and two carbon-nitrogen bonds

Dahl, Troels,Tornoe, Christian W.,Bang-Andersen, Benny,Nielsen, Poul,Jorgensen, Morten

supporting information; scheme or table, p. 1726 - 1728 (2009/02/06)

(Chemical Presented) Zip it up! The use of a Pd/dppf catalyst gives access to the tricyclic phenothiazine scaffold starting from 1-bromo-2-iodobenzenes, aliphatic or aromatic amines, and 2-bromothiophenols in a single reaction flask (see scheme; dppf=1,1′-bis(diphenylphosphanyl) ferrocene; dba=dibenzylidineacetone). This transformation involves thioether formation and subsequent intermolecular and intramolecular aryl amination reactions. The reaction occurs in good overall yield and selectivity.

Heterocyclic compounds

-

, (2008/06/13)

A compound of formula (I): STR1 in which X, n, B and Y are as defined in the description. useful as cytokine inhibitors.

Radiolytic Reductions and Oxidations in Dimethyl Sulfoxide Solutions. Solvent Effects on Reactivity of Halogen Atom Complexes

Kumar, M.,Neta, P.

, p. 3350 - 3354 (2007/10/02)

Radiolysis of dimethyl sulfoxide (DMSO) solutions containing various additives was used to achieve clean one-electron reduction or oxidation of solutes.Pulse radiolysis of benzoquinone in DMSO solutions containing acetone and triethylamine permitted conversion of all primary radicals into reducing species.The total yield of reduction in the γ-radiolysis of methyl viologen solutions was found to be 0.37 μmol/J.In the pulse radiolysis of TMPD and triphenylamine in aerated DMSO containing LiCl and/or CCl4, all the primary radicals were converted into oxidizing species and gave a maximum yield of 0.39 μmol/J.In the latter systems, oxidation was partly by halogen atom complexes.The reactivity of complexes of DMSO (DMSO*Cl, DMSO*Br) and of halide ions (Br2.1-, I2.1-) was examined for several organic compounds.DMSO*Cl oxidizes chlorpromazine, triphenylamine, and zinc porphyrin with rate constants of the order of 1E7-1E8 M-1 s-1, and the rates increase upon addition of CH2Cl2 as well as upon addition of water and formamide.DMSO*Cl also reacts with olefins by addition of Cl to the double bond; the rate constants increase upon increasing the electron-donating properties of the substituents on the double bond.The rate constants for oxidation of chlorpromazine by Br2.1- and I2.1- increase by more than 2 orders of magnitude upon changing the solvent from DMSO gradually to water.The change was less with acetonitrile/water mixtures, and the difference is probably due to differences in ion solvation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 50-53-3